Mad Money: Key points from April 17, 2023 (Monday) Episode

Home Forums Investments in the US Summary of CNBC “Mad Money” Episodes Mad Money: Key points from April 17, 2023 (Monday) Episode

  • This topic is empty.
Viewing 0 reply threads
  • Author
    Posts
    • #6934

      This page contains summary of CNBC program “Mad Money w/ Jim Cramer” which was on air on Monday, April 17, 2023.  It also contains links to CNBC sites which contain video clips and transcripts.

       

      (1) Investors shouldn’t be ‘shadowboxing’ with recession fears, Jim Cramer says (https://www.cnbc.com/2023/04/17/jim-cramer-investors-shouldnt-be-shadowboxing-with-recession-fears.html)

      • Investors shouldn’t be “shadowboxing” with inflation fears, CNBC’s Jim Cramer said.
      • Instead, they should look for opportunity amidst a bull market that has continued despite commentator fears for months, Cramer argued.

       

      (2) [No Video Clip for non-Club Member] Executive Interview: InMode CEO Moshe Mizrahy on the company’s minimally-invasive medical tech (https://www.cnbc.com/video/2023/04/17/inmode-ceo-moshe-mizrahy-on-the-companys-minimally-invasive-medical-tech.html)

      Moshe Mizrahy, chairman and CEO of InMode, joins “Mad Money” to discuss the company’s medical technology and its better-than-expected earnings.

      Ticker: INMD

       

      (3) [No Video Clip for non-Club Member] Off-the-Chart: Jim Cramer checks the charts to find out what trader sentiment says about the S&P (https://www.cnbc.com/video/2023/04/17/jim-cramer-checks-the-charts-to-find-out-what-trader-sentiment-says-about-the-sp.html)

      “Mad Money” host Jim Cramer breaks down the CFTC COT report to understand large, small and speculative trader sentiment.

       

      (4) [No Video Clip] Executive Interview

      fresh off the announcement that Merck will buy Prometheus Biosciences for $11b, Cramer’s talking to Merck CEO Rob Davis and Prometheus CEO Mark McKenna to dig deeper into what the deal will mean for investors and patients.

      Ticker: MRK, RXDX

       

      (5) Lightning Round: Nike’s No. 1 in sports apparel (https://www.cnbc.com/video/2023/04/17/lightning-round-nikes-no-1-in-sports-apparel.html)

      “Mad Money” host Jim Cramer weighs in on stocks, including TG Therapeutics, Eastman Chemical, and Nike.

      Ticker: TGTX [I like the stock], EMN [Feel very negative about the group], APPN [I don’t like, too may of them], NKE [I like NKE, buy buy buy, I am a buyer of ON [Holdings]], BA [BA worries me, You have to stay away from BA for now], SYN [I need to do some work as I don’t know why it is doing that well]

       

      (6) [No Video Clip for non-Club Member] Cramer: Google has the most to lose from A.I. since it’s closely related to search (https://www.cnbc.com/video/2023/04/17/cramer-google-has-the-most-to-lose-from-ai-since-its-closely-related-to-search.html)

      “Mad Money” host Jim Cramer discusses the impact that growing artificial intelligence adoption could have on tech giant Google.

      Ticker: GOOGL [Charitable Trust owns GOOGL]

       

      Other Stocks Discussed (calls with audience): Uber (UBER) [Uber is great], Dutch Bros (BROS) [Incredible well, one of the better long story in the market, like Five Below (FIVE) 5 years ago], McDonald (MCD) [It is best in show other than Chipotle (CMG)]

       

      Ref: Links to other sites that relate to episode of April 17, 2023

      Disclaimer

      ****************************

      Previous episode Next Episode
Viewing 0 reply threads
  • The topic ‘Mad Money: Key points from April 17, 2023 (Monday) Episode’ is closed to new replies.
Copied title and URL